AXCELLA HEALTH - Trademark Details
Status: 819 - SU - Registration Review Complete
Image for trademark with serial number 87062063
Serial Number
87062063
Word Mark
AXCELLA HEALTH
Status
819 - SU - Registration Review Complete
Status Date
2022-02-10
Filing Date
2016-06-06
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2020-06-02
Law Office Assigned Location Code
L10
Employee Name
MAKHDOOM, SAIMA
Statements
Disclaimer with Predetermined Text
"HEALTH"
Goods and Services
proteins, biochemicals in the nature of polypeptides and peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in scientific and medical research; nutrients and nutritive products, namely, proteins in the nature of polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in the manufacture of beverages, food products and food supplements for human and non-human use; proteins for the food industry in the nature of proteins, polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; biochemicals for in vitro and in vivo scientific research
Goods and Services
Dietary supplements for human and animal use; dietary supplements for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, and joints; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints; dietary and nutritional supplements
Goods and Services
Research and development of products in the nature of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; characterization of metrics and biomarkers, namely, development and evaluation of biochemical, biological, or analytical assays to quantify biomarkers and surrogate markers, and epidemiological and natural history studies, for the identification of patients and the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-06-14
Primary Code
005
First Use Anywhere Date
2021-11-05
First Use In Commerce Date
2021-11-05
Current Trademark Owners
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Christina M. Licursi, Esq.
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Continuity Child87983740
Trademark Events
Event DateEvent Description
2016-06-09NEW APPLICATION ENTERED IN TRAM
2016-06-14NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-09-16ASSIGNED TO EXAMINER
2016-09-16NON-FINAL ACTION WRITTEN
2016-09-16NON-FINAL ACTION E-MAILED
2016-09-16NOTIFICATION OF NON-FINAL ACTION E-MAILED
2017-02-15TEAS CHANGE OF CORRESPONDENCE RECEIVED
2017-03-16TEAS RESPONSE TO OFFICE ACTION RECEIVED
2017-03-16CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-03-16TEAS/EMAIL CORRESPONDENCE ENTERED
2017-04-05FINAL REFUSAL WRITTEN
2017-04-05FINAL REFUSAL E-MAILED
2017-04-05NOTIFICATION OF FINAL REFUSAL EMAILED
2017-09-20TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2017-09-20ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2017-10-05EXPARTE APPEAL RECEIVED AT TTAB
2017-10-05JURISDICTION RESTORED TO EXAMINING ATTORNEY
2017-10-05EX PARTE APPEAL-INSTITUTED
2017-10-05TEAS REQUEST FOR RECONSIDERATION RECEIVED
2017-10-18ASSIGNED TO LIE
2017-10-23CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-10-23TEAS/EMAIL CORRESPONDENCE ENTERED
2017-10-23APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2017-10-26NON-FINAL ACTION WRITTEN
2017-10-26NON-FINAL ACTION E-MAILED
2017-10-26NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-04-09TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-04-09CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-04-10TEAS/EMAIL CORRESPONDENCE ENTERED
2018-05-07SUSPENSION LETTER WRITTEN
2018-05-07LETTER OF SUSPENSION E-MAILED
2018-05-07NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2018-11-07REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2019-05-11REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2019-05-11REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2019-11-11REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2020-04-28TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2020-04-30CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-04-30TEAS/EMAIL CORRESPONDENCE ENTERED
2020-04-30APPROVED FOR PUB - PRINCIPAL REGISTER
2020-05-13NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-06-02PUBLISHED FOR OPPOSITION
2020-06-02OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-07-28NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2021-01-28TEAS EXTENSION RECEIVED
2021-01-28TEAS REQUEST TO DIVIDE RECEIVED
2021-02-16CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-01-28DIVISIONAL REQUEST RECEIVED
2021-02-22DIVISIONAL PROCESSING COMPLETE
2021-01-28EXTENSION 1 FILED
2021-02-22EXTENSION 1 GRANTED
2021-02-23NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-02-23CORRECTED NOA E-MAILED
2021-07-27TEAS EXTENSION RECEIVED
2021-07-27EXTENSION 2 FILED
2021-07-27EXTENSION 2 GRANTED
2021-07-29NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2022-01-28TEAS STATEMENT OF USE RECEIVED
2022-01-28USE AMENDMENT FILED
2022-02-03STATEMENT OF USE PROCESSING COMPLETE
2022-02-10ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2022-02-11NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED